We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Swiss Regulator Lacks Authority to OK Generics, Will Focus on ‘Known APIs’
Swiss Regulator Lacks Authority to OK Generics, Will Focus on ‘Known APIs’
November 11, 2013
Beginning in 2014, Switzerland’s therapeutic product regulator will no longer be approving “generics,” and will instead only authorize known active pharmaceutical ingredients.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor